H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 14.7% of adults in Milwaukee have diagnosed diabetes — 2.7 points above the U.S. 12% figure. Census population 577,222. Wisconsin Medicare wound biologics: National Government Services (NGS) (J6). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Milwaukee clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Milwaukee storefront.
Fibrin Matrix Therapy Products in Milwaukee, WI for clinics & physicians. Fibrin matrix therapy supports w… Compliance support & pricing — contact Hawk Medical.
If a sales sheet cannot tell you that Milwaukee is J6 (National Government Services (NGS)) and that adult diabetes here is 14.7% (PLACES 2023), it is selling units, not a program. That is the fibrin matrix therapy conversation we actually have.
National Fibrin Matrix Therapy Products notes (how the product actually works)Wisconsin shares J6 with IL, MN. Florida is the only single-state MAC. CDC PLACES (2023, crude) estimates 14.7% of adults in Milwaukee have diagnosed diabetes — 2.7 points above the U.S. 12% figure. If you also operate in another contractor’s state, say so on the first call — we map both.
Practices hire us when the fridge is full and the chart is a mess. CDC PLACES (2023, crude) estimates 14.7% of adults in Milwaukee have diagnosed diabetes — 2.7 points above the U.S. 12% figure. That is a planning input. The work is still receiving, indication language, and not mixing PRP with CTP codes. That is the fibrin matrix therapy account.
CDC PLACES (2023, crude prevalence) estimates 14.7% of adults — 2.7 points above the U.S. 12% figure. Obesity is 41.8%; arthritis is 23.8%. That is place-level BRFSS modeling, not a clinic census and not a Milwaukee trial.
Start with the CDC National Diabetes Statistics Report and America's Health Rankings diabetes measure (BRFSS). Wisconsin Department of Health Services is the state public-health home. Those are the citable sources — not this page’s city name in a headline.
The 96.5% figure is a product-level clinical experience statistic published on our wound-care materials — not a city-specific trial. Your outcomes will depend on patient selection, offloading, and follow-up.
We source from FDA-registered banks. Bank location is not the same as Hawk Medical’s distribution address, and it is not a Milwaukee clinic. Ask for the bank’s registration and AATB status on the SKU you want.
Bring specialty, monthly wound volume, and whether you bill J6 FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 14.7% diabetes and 23.8% arthritis for Milwaukee — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Milwaukee, WI.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Milwaukee is J6 geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Milwaukee — 2.7 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Wisconsin Part B wound biologics follow this contractor (siblings: IL, MN). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Milwaukee. Useful for joint-program math; still needs a diagnosis and privileging.
No Milwaukee storefront. Joe Bradley is an active practice owner. fibrin matrix therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.